iRhythm (IRTC) CAO trades 280 shares under pre-set 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
iRhythm Holdings, Inc. Chief Accounting Officer Marc Wade Rosenbaum reported an open-market sale of 280 shares of common stock at an average price of $140.91 per share on February 24, 2026. After this sale, he directly holds 10,601 shares of iRhythm common stock.
The transaction was executed under a pre-arranged Rule 10b5-1 trading plan that he established on May 12, 2025 and modified on November 25, 2025, which is designed to allow systematic share sales according to preset instructions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 280 shares ($39,455)
Net Sell
1 txn
Insider
Rosenbaum Marc Wade
Role
Chief Accounting Officer
Sold
280 shs ($39K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 280 | $140.91 | $39K |
Holdings After Transaction:
Common Stock — 10,601 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did iRhythm (IRTC) report for Marc Wade Rosenbaum?
Marc Wade Rosenbaum, iRhythm’s Chief Accounting Officer, sold 280 shares of common stock. The sale occurred on February 24, 2026 at an average price of $140.91 per share, and was reported on a Form 4 insider trading filing with the SEC.
Was the iRhythm (IRTC) insider sale made under a Rule 10b5-1 trading plan?
Yes. The Form 4 states the sale was effected under a Rule 10b5-1 trading plan. Marc Wade Rosenbaum established this plan on May 12, 2025 and later modified it on November 25, 2025, providing preset instructions for executing trades.
What role does Marc Wade Rosenbaum hold at iRhythm (IRTC) in this Form 4 filing?
Marc Wade Rosenbaum is identified as the Chief Accounting Officer of iRhythm Holdings, Inc. His officer status is disclosed in the filing, which reports his direct ownership and the sale of 280 shares of the company’s common stock on February 24, 2026.